TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. It also involves developing TG-1101 and TGR-1202 therapies targeting hematological malignancies. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY.
Market Cap | 628.396 Million | Shares Outstanding | 142.817 Million | Avg 30-day Volume | 4.363 Million |
P/E Ratio | 0.0 | Dividend Yield | 0.0 | EPS | -2.63 |
Price to Revenue | 161.5456 | Debt to Equity | 0.3947 | EBITDA | -317.848 Million |
Price to Book Value | 7.5015 | Operating Margin | -4075.3286000000003 | Enterprise Value | 1.065 Billion |
Current Ratio | 4.432 | EPS Growth | 0.068 | Quick Ratio | 4.283 |
1 Yr BETA | 2.2236 | 52-week High/Low | 41.0 / 3.48 | Profit Margin | -4126.4661 |
Operating Cash Flow Growth | -21.0574 | Altman Z-Score | -3.3927 | Free Cash Flow to Firm | -231.106 Million |
Earnings Report | 2022-08-01 |
Please sign in first
none
none
none
Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
---|---|---|---|---|
POWER SEAN A CFO, SECRETARY AND TREASURER |
|
568,483 | 2022-01-04 | 1 |
WEISS MICHAEL S CEO AND PRESIDENT |
|
24,443,718 | 2021-12-29 | 1 |
|
220,997 | 2021-06-18 | 0 | |
|
149,116 | 2021-06-18 | 0 | |
|
178,953 | 2021-06-18 | 0 | |
|
154,507 | 2021-06-18 | 0 | |
|
85,000 | 2021-06-18 | 0 | |
|
7,614,855 | 2015-02-17 | 0 | |
|
51,265 | 2012-12-06 | 0 |
Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No current insider transactions |
* -
Code | Definition |
---|---|
A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
C | Conversion of derivative security |
D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
G | Bona fide gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
J | Other acquisition or disposition |
L | Small acquisition under Rule 16a-6 |
M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
O | Exercise of out-of-the-money derivative security |
P | Open market or private purchase of non-derivative or derivative security |
S | Open market or private sale of non-derivative or derivative security |
U | Disposition pursuant to a tender of shares in a change of control transaction |
W | Acquisition or disposition by will or the laws of descent and distribution |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
---|---|---|---|---|
TG THERAPEUTICS INC TGTX | 2022-06-24 22:15:03 UTC | 1.1402 | 0.4298 | 2300000 |
TG THERAPEUTICS INC TGTX | 2022-06-24 21:45:03 UTC | 1.1402 | 0.4298 | 2300000 |
TG THERAPEUTICS INC TGTX | 2022-06-24 21:15:04 UTC | 1.1402 | 0.4298 | 2300000 |
TG THERAPEUTICS INC TGTX | 2022-06-24 20:45:03 UTC | 1.1402 | 0.4298 | 2300000 |
TG THERAPEUTICS INC TGTX | 2022-06-24 20:15:03 UTC | 1.1402 | 0.4298 | 2300000 |
TG THERAPEUTICS INC TGTX | 2022-06-24 19:45:03 UTC | 1.1402 | 0.4298 | 2300000 |
TG THERAPEUTICS INC TGTX | 2022-06-24 19:15:03 UTC | 1.1402 | 0.4298 | 2300000 |
TG THERAPEUTICS INC TGTX | 2022-06-24 18:45:03 UTC | 1.1402 | 0.4298 | 2300000 |
TG THERAPEUTICS INC TGTX | 2022-06-24 18:15:04 UTC | 1.1402 | 0.4298 | 2300000 |
TG THERAPEUTICS INC TGTX | 2022-06-24 17:45:03 UTC | 1.1402 | 0.4298 | 2300000 |
TG THERAPEUTICS INC TGTX | 2022-06-24 17:15:03 UTC | 1.1402 | 0.4298 | 2300000 |
TG THERAPEUTICS INC TGTX | 2022-06-24 16:45:03 UTC | 1.1426 | 0.4274 | 2300000 |
TG THERAPEUTICS INC TGTX | 2022-06-24 16:15:03 UTC | 1.1426 | 0.4274 | 2300000 |
TG THERAPEUTICS INC TGTX | 2022-06-24 15:45:03 UTC | 1.1426 | 0.4274 | 2300000 |
TG THERAPEUTICS INC TGTX | 2022-06-24 15:15:03 UTC | 1.1426 | 0.4274 | 2300000 |
TG THERAPEUTICS INC TGTX | 2022-06-24 14:45:03 UTC | 1.143 | 0.427 | 2300000 |
TG THERAPEUTICS INC TGTX | 2022-06-24 14:15:03 UTC | 1.143 | 0.427 | 2300000 |
TG THERAPEUTICS INC TGTX | 2022-06-24 13:45:03 UTC | 1.143 | 0.427 | 2300000 |
TG THERAPEUTICS INC TGTX | 2022-06-24 13:15:03 UTC | 1.143 | 0.427 | 2200000 |
TG THERAPEUTICS INC TGTX | 2022-06-24 12:45:03 UTC | 1.143 | 0.427 | 2200000 |
Holder | Issuer | Net Short Position | Position Date | Origin |
---|---|---|---|---|
FundVantage Trust- Gotham Master Neutral Fund | TGTX | -1.0 shares, $-26.76 | 2020-09-30 | N-PORT |
Trust for Professional Managers- Convergence Long/Short Equity Fund | TGTX | -1239.0 shares, $-18832.8 | 2021-11-30 | N-PORT |
CLOUGH GLOBAL LONG/SHORT FUND- Clough Global Long/Short Fund | TGTX | -9280.0 shares, $-107369.6 | 2022-01-31 | N-PORT |
PACE SELECT ADVISORS TRUST- PACE Alternative Strategies Investments | TGTX | -16450.0 shares, $-190326.5 | 2022-01-31 | N-PORT |
Columbia Funds Series Trust I- Multi-Manager Directional Alternative Strategies Fund | TGTX | -19750.0 shares, $-228507.5 | 2022-01-31 | N-PORT |
Columbia Funds Series Trust I- Multi-Manager Directional Alternative Strategies Fund | TGTX | -19750.0 shares, $-228507.5 | 2022-01-31 | N-PORT |
RUSSELL INVESTMENT CO- Sustainable Equity Fund | TGTX | -1252.0 shares, $-14485.64 | 2022-01-31 | N-PORT |
CLOUGH GLOBAL EQUITY FUND- Clough Global Equity Fund | TGTX | -56480.0 shares, $-653473.6 | 2022-01-31 | N-PORT |
CLOUGH GLOBAL OPPORTUNITIES FUND- Clough Global Opportunities Fund | TGTX | -105120.0 shares, $-1216238.4 | 2022-01-31 | N-PORT |
FundVantage Trust- Gotham Hedged Plus Fund | TGTX | -179.0 shares, $-1702.29 | 2022-03-31 | N-PORT |
Trust for Professional Managers- Convergence Long/Short Equity ETF | TGTX | -1239.0 shares, $-5476.38 | 2022-05-31 | N-PORT |
INVESTMENT MANAGERS SERIES TRUST- 361 Domestic Long/Short Equity Fund | TGTX | -286.0 shares, $-1984.84 | 2022-04-30 | N-PORT |
INVESTMENT MANAGERS SERIES TRUST- 361 Global Long/Short Equity Fund | TGTX | -171385.0 shares, $-1189411.9 | 2022-04-30 | N-PORT |